Statistics

Total Visits

Views
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol study 84
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol study 23

Total Visits per Month

January 2024 February 2024 March 2024 April 2024 May 2024 June 2024 July 2024
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol study 1 1 3 6 6 1 0

File Downloads

Views

Top Country Views

Views
United States 44
China 13
Netherlands 8
Vietnam 8
Australia 6
France 5
Singapore 5
Germany 4
Ireland 1

Top City Views

Views
Ashburn 18
Hanoi 8
Rotterdam 8
Fairfield 5
Beijing 4
Singapore 4
Brisbane 3
Boardman 2
New York 2
Adelaide CBD 1